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ABSTRACT
The frequency of colony formation in monolayers of cultured frog cell lines treated with
puromycin was compared in (a) haploid and heteroploid lines and (b) mutagen-treated
and nontreated haploid lines. Evidence that resistant colonies result from gene mutation
was negative, since the colony frequency is independent of both ploidy and mutagen
treatment. A study of five frog cell lines showed that colony formation in puromycin de-
pends on (a) the concentration of puromycin, (b) preselection of the population with puro-
mycin, and, particularly, (c) the capacity of the treated population to survive some exposure
to puromycin . One haploid and one heteroploid strain showing stable resistance to puro-
mycin have been isolated ; comparison of those variants with sensitive populations has
shown that resistance to puromycin is correlated with the cells' capacity to exclude the
drug. The evidence for different levels of membrane permeability, combined with evidence
for many degrees of resistance among and within cell populations, suggests a model of
self-determining membrane units . The evolution of a resistant phenotype may result
from changes in the proportion of specific units in the membrane population .
INTRODUCTION
Investigations of mutation in cell culture have
been complicated by the uncertainty that a
variant arising in culture is the result of gene
mutation (changes in DNA base sequence) or of
an extragenic event (1, 2) . This difficulty can be
attributed in part to the absence of effective
segregation tests and the spurious colony forma-
tion which complicates a Luria-Delbrück analysis .
In cases where the variant phenotype has been
correlated with a molecular difference, it is still
not certain that there has been a genetic change .
The nature of these heritable changes is par-
ticularly hard to determine in drug-resistant
variants, as has been demonstrated by Harris for
puromycin resistance in cultures of pig kidney
cells (3) .
A second difficulty of cell culture mutation ex-
periments has been the absence of a haploid cell
line, in which recessive gene mutations could be
detected and isolated. In such a line, any pheno-
typic change resulting from a recessive gene
mutation would be expected to occur with many
times (1 /mutation rate) the frequency observable
in a diploid population; the frequency should be
further increased by treatment with mutagens.
The first such vertebrate lines, derived from em-
bryos of the frog Rana pipiens (4), were used in the
studies reported here .
A comparison of the development of puromycin-
resistant variants in the haploid population with
that in heteroploid lines was undertaken to test
the hypothesis that such variants were the result
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below indicate that colony production in puro-
mycin is independent of both cell ploidy and
pretreatment with mutagens . An analysis of a
number of cell populations and resistant variants
suggests that the degree of resistance is (a) de-
pendent on a large number of units and (b) cor-
related with a decreased permeability to the drug .
A model of self-determining membrane units
could explain both the heritability of puromycin
resistance and the formation of variants ; it may
also be applicable to some phenotypic changes
which occur in differentiation and tumorigenesis.
MATERIALS AND METHODS
The origin and maintenance of the five sensitive
("wild-type") frog cell lines studied has been de-
scribed elsewhere (4-6). The two lines which have
yielded resistant variants are the haploid ICR 2A
and the pseudodiploid ICR 132 ; both were initiated
from haploid Rana pipiens embryos. They have now
been maintained for over 100 subcultures (a sub-
culture, S,1 corresponds to 3-4 generations) ; they
multiply in 60% L-15 medium with 107 fetal calf
serum at 25°C with a doubling time of 40 hr (6).
A typical procedure was as follows: about 2-3 X
105 trypsinized cells were inoculated into 12 ml of
standard medium in a 75 cm 2 plastic flask. When
the cells had formed a monolayer of about 2 X 10 6
cells, freshly prepared medium of the appropriate
concentrations of puromycin was added to the drained
flasks; the solution was renewed every 10 days. The
puromycin dihydrochloride stock solution (50 µg/ml)
was kept frozen when not in use. The decrease or
increase in cell number was followed by counting
the cells in situ using an inverted microscope fitted
with a net reticule. Flasks were examined weekly
for the appearance of colonies visible to the eye.
When most of the colonies in a flask contained a
minimum of 100 cells, the side of the flask over the
colonies was removed with a soldering iron ; indi-
vidual colonies were then harvested by the steel
cylinder method and dispersed into 2 ml of standard
medium (without puromycin) .
For determinations of puromycin uptake, 25 cm 2
flasks containing monolayers of cells were set up;
before testing, the cells were allowed to multiply in
medium without puromycin for at least a week .
Puromycin 5H (SA 1.11 Ci/mmole) in standard
medium was added to the drained flasks ; after a
specified time, the solution was decanted and the
flask washed with 5 ml salt solution with 2.5 µg/ml
1 Abbreviations: C, clone ; EMS, ethylmethanesul-
fonate ; I, impermeable; MNNG, N-methyl-N'-nitro-
N-nitrosoguanidine; P, permeable; S, subculture.
cold puromycin. After the cells were detached by
trypsinization, they were poured onto a Millipore
filter disc (Millipore Corporation, Bedford, Mass .)
and again washed with the salt and cold puromycin
solution. After drying was completed, the radio-
activity was determined by scintillation spectroscopy .
For calculations of internal puromycin concentration,
cell diameters were determined with a Vickers
image-splitting eyepiece (Vickers Instruments, Inc .,
Malden, Mass.) .
RESULTS
Reaction of Cell Populations to Puromycin
A typical curve for the relation of survival to
concentration of drug is shown in Fig. I ; all of
the frog lines tested have given such a biphasic
curve, with the break between 2 and 4 µg/ml
puromycin. Each cell line shows a different and
typical level of response, although the level may
change over large numbers of cell generations .
The reaction to puromycin is independent of
ploidy (and therefore cell size) since one haploid
line, ICR 2A, and a diploid line, ICR 132, have
high survival rates while the haploid line ICR 205
and a pseudotriploid line, ICR 134C4 , fare rela-
tively badly in the drug (Fig. 2 and Table I).
Cell lines initiated from sibling embryos can differ
in their survival in puromycin, as in the case of
ICR 132 and 13404 .
The relationship between cell population and
duration of drug treatment also gives a biphasic
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FIGURE 1 Survival of cultured frog cells from line ICR
132 (S24) as a function of puromycin concentration. The
ordinate is the number of attached cells remaining after
a 72 hr exposure to puromycin as a per cent of the
number present at zero time.
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FIGURE 2 Comparison of the survival of cultured frog cells of different ploidy values as a function of
puromycin concentration. The cell lines are : Fig. 2 a, ICR 2A S26, haploid ; ICR 205 S31 , haploid; ICR
132 S;7 , pseudodiploid; Fig. 2 b, ICR 2A S39 , haploid ; ICR 205 S41 , haploid; ICR 134C4 S55 , pseudo-
triploid. Fig. 2 a shows survival after 6 days, Fig. 2 b after 7 days of puromycin treatment.
TABLE I
Cell Survival and Colony Formation of Haploid,
Heteroploid, and Puromycin-Selected Frog Lines
in Puromycin
Survival in Colony formation
	
I µg/ml
* Each datum represents the colony count in one
flask containing 106 cells at the time of puromycin
application. No colonies were found at 4, 6, and
10,ug/ml puromycin in these experiments .
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curve (Fig. 3). There is, therefore, in a "sensitive
population" a group of cells which is able to with-
stand longer periods as well as higher doses of
puromycin. It is evident from Fig. 4 that after 3
or 4 wk, at least some of these cells not only
survive but multiply for a time in concentrations
up to 2 mg/ml of puromycin . If the slopes of the
lines showing the resulting increase in cell number
are extrapolated back to zero, a figure is obtained
for the fraction of cells present at that time which
were able to multiply in puromycin at the con-
centration in the flask (see Fig. 5). The fraction of
cells able to multiply is correlated with the con-
centration of puromycin . A sensitive population
consists, therefore, of cells differing in their capaci-
ties to synthesize protein and to multiply in the
presence of puromycin.
A more resistant portion of such a sensitive
population can be selected by treating with low
levels of puromycin. If cells which survive 1
pg/ml puromycin for 7 wk are allowed to multiply
in drug-free medium and are treated again, the
observed resistance is higher than that of the
parent line (Fig . 3) . However, if propagation in
drug-free medium is longer continued (e.g., 50
generations; see Fig. 3), the resistance is lower.
The character of resistance is not completely stable
although it remained higher than that of the
parent line for many generations . Therefore, one
of the results of cell multiplication in medium
og /ml 1
	
2 3 1 wk 2 wk
No. of colonies* %
Haploid
2A(S26) 11 0 0
16 0 0 16 9
205(S31) 0 0 0
0 0 0 1 0.1
Pseudodiploid
132(S40) 39 1 0
45 0 0 26 8
132 puro(S19) 54 3 1
5 2 22 20
132 puroCl4(S6) Many 4 0
Many 4 1 23 18
Pseudotriploid
134C4 0 0 0
0 0 0 6 41.0
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FIGURE 3 Comparison of survival in puromycin (2
,ug/ml) of a sensitive cell line ICR 132 S24 (O) and a cell
strain derived from ICR 132 S24 by treatment with
1 µg/ml puromycin. The cell strain was tested several
generations after it was removed from puromycin (C)
and after 6 months of multiplying in the absence of
puromycin (•).
without puromycin is the production of a series
of less resistant cells . Evidence that cells with
higher resistance are also produced under these
circumstances is the fact that these populations
yield colonies at concentrations of puromycin
in which none had previously been found, as
discussed in the next section.
Colony Formation
Colonies (64 or more cells) become visible from
3 to 7 wk after continuous puromycin treatment,
indicating that there is a lag or delay in cell divi-
sion upon exposure to the drug. The frequency of
colonies is dependent on (a) the drug concen-
tration, (b) the particular cell line exposed to the
drug, and (c) whether or not preselection by
puromycin treatment has occurred . Their appear-
ance is not sporadic as would be expected with a
single mutation ; colonies at a given concentration
are always accompanied by more frequent colonies
at a lower concentration. For example, in the
experiment depicted in Fig. 4, the average number
of colonies at the 2.5 µg/ml concentration was 2 ;
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FIGURE 4 Survival and multiplication of cultures of
ICR 132 S24 cells in puromycin for 38 days. The arrows
indicate the times at which the medium was replaced
with fresh puromycin medium .
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FIGURE 5 The relation of the fraction of the sensitive
cell population able to multiply in puromycin to the
concentration of puromycin . The values for the ordinate
were obtained by graphically extrapolating to zero in
Fig. 4.
at 2.0 µg/ml, 5 colonies; at 1 .5 µg/ml, 40 colo-
nies; and at 1 .0 µg/ml, 60 colonies. The data in
Table I also illustrate this point and furthermore
show that the ploidy of a cell line does not deter-
mine the yield of colonies. The one property of a
cell line which is correlated with the formation
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745of colonies is the capacity of the culture to survive
the first week or two of puromycin treatment as
shown in Table I .
To determine the extent and stability of the
resistance to puromycin, 37 individual colonies
were harvested from 1 ug/ml puromycin . When
the progeny cultures were reexposed to puromycin,
they showed a wide range of capacities to survive
in puromycin. The average cell survival for all
the isolates was 10 times that of the parent line
but was still not adequate for a population increase
in 1 jug/ml puromycin. The increase in the pro-
portion of cells able to survive some puromycin
treatment is accompanied upon reexposure to
puromycin by the eventual appearance of more
colonies at higher concentrations of drug (Table I,
132 puro and 132 puroCt4), thus confirming the
relationship between survival of the monolayers
and frequency of colonies. Colonies appear in 3
ug/ml only after a second exposure to puromycin,
indicating that selection and subsequent cell mul-
tiplication results in more highly resistant cells .
Mutagenesis
A further test for the possible genetic origin of
colonies was made by treating the haploid cells
with mutagens before exposure to puromycin .
Two compounds which produce mutants in bac-
teria and which had resulted in auxotrophic vari-
ants in Chinese hamster cells were tried; these
are ethylmethanesulfonate (EMS) and N-methyl-
N'-nitro-N-nitrosoguanidine (MNNG) (7-9).
The results of mutagen treatments yielding
25-50% cell survival are given in Table II . In
1 ug/ml puromycin, colonies from mutagen-
treated populations appear earlier and are there-
fore larger than those in normal populations, but
the final number of colonies is about the same. In
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2-5 ug/ml puromycin, out of a total of 92 flasks,
2 MNNG-treated flasks had colonies ; these may
be the result of a single event since the popula-
tions came from the same pool before drug appli-
cation. The only other experiment which pro-
duced colonies in such high concentrations of
puromycin was in ICR 132(S 57), a pseudo-
diploid, nonmutagen-treated population. There is
therefore no significant evidence that mutagen
treatment of haploid cells increases colony forma-
tion in puromycin .
Resistant Strains
From several hundred colonies harvested from
cultures treated with puromycin, two highly re-
sistant strains have been obtained ; these multiply
in medium containing concentrations of puro-
mycin up to 10 ug/ml. Isolation of the haploid
variant, ICR 2A puro 374, began with exposure
to 1 pg/ml puromycin of ICR 2A cells previously
treated with EMS (300 ug/ml) . In this experi-
ment, 11 colonies were tested for resistance ; only
No. 37 was able to multiply in 2 pg/ml puromycin.
The level of resistance decreased when the cells
grew in the absence of the drug ; after 20 genera-
tions, reexposure to a 2 ug/ml concentration
killed the cells, leaving only four colonies . The
progeny of one of the colonies was exposed to
5 pg/ml puromycin; the colony which resulted,
No. 374, produced the haploid strain ICR 2A
puro 374. The cells multiply in 10 jug/ml puro-
mycin but resistance decreases if they are cultivated
in the absence of the drug. The plating efficiency
is zero at 10 pg/ml and 2% in 2 ug/ml. In appear-
ance, the cells are like fibroblasts with some tend-
ency toward parallel orientation which increases
with exposure to puromycin . By contrast, the
TABLE II
Colony Production by the Haploid Cell Line ICR 2A before and after
Treatment with Mutagens
* Numbers in parentheses are total number of cells treated .
Puromycin
conc.
Mutagen treatment
None EMS (300 mg /ml) MNNG (1.5 µg /ml)
µg/ml colonies /106 cells colonies /106cells colonies /106 celis
1 85 (5 X 106)* 95 (5 X 106 ) 92 (5 X 106)
2 0 (2 X 106 ) 0 (2 X 106)
3 0 (2 X 106) 0 (2 X 106) 0 (2 X 106)
5 0 (10 X 106) o (30 X 106) 0.1 (40 X 106)sensitive parent ICR 2A cells are spindle shaped
and do not show contact inhibition of movement .
A second, more resistant variant was obtained
from the pseudodiploid line ICR 132 without the
kind of cycling procedure used for puro 374.
ICR 132 puro 46 started as a large colony which
grew in a flask of cells treated with 10 µg/ml
puromycin. In this particular experiment, colonies
arose in all of the flasks set up from a pool of
ICR 132(S57) cells, including those with con-
centrations of puromycin at which colonies have
not before or since been found (6-10 µg/ml).
However, in this experiment there was no sig-
nificant increase in the survival of the cell mono-
layer as a whole. These observations are consistent
with the presence of a small group of resistant
cells in the inoculum before puromycin was ap-
plied. Such a reservoir is not characteristic of the
line itself, as experiments at passages 24, 30,
40, 102, and 110 have shown. In order to obtain
this highly resistant heteroploid variant, no further
exposure to puromycin was necessary. From its
isolation, it maintained the capacity to multiply
in 10 µg/ml, even after 18 passages in the absence
of the drug. There is evidence that a small, less
resistant population accumulates in the absence of
selective pressure from puromycin : when cultures
are returned to the drug, there is a short lag in
multiplication, a lag which is more severe at higher
TABLE III
Uptake of Tritiated Puromycin by Frog Cell Strains
drug concentrations. The remaining cells then
multiply at the same rate as in the absence of the
drug. However, even after 150 generations in the
absence of puromycin, most of the population
multiplies when returned to 10 µg/ml puromycin .
By exposure to higher concentration of puromycin,
cells have been selected which grow in 20 µg/ml
but not 50 µg/ml of the drug. The plating effi-
ciency of ICR 132 puro 46 in 2 µg/ml (11 %) is
almost as high as in the absence of drug (15%) and
is the same as that of the parent line in normal
medium. In 10 µg/ml puromycin, only 2% of
the cells produce colonies under plating condi-
tions. The puromycin resistant variant of ICR 132
is fibroblast-like in appearance as is the parent
line; they are both partially contact inhibited.
However, the variant has larger cells than the
parent strain; it is essentially hypotetraploid with
a modal chromosome number of 45 (n = 13) .
Puromycin Uptake
We have been unable to find in the literature
any explanation of how resistant cultured cells
avoid the effect of puromycin. The first question
we posed was that of entry . It was found that ICR
132 puro 46 takes up only about 10% as much
puromycin per cell as its parent line ; for ICR 2A
puro 374, the uptake is one-third as much as the
sensitive parent line (Table III) .
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Exp. Date ICR 132 ICR 132 puro 46 ICR 2A ICR 2A pure, 374
cpm /106 cell % cpm /106 cell % cpm /10 6cell % cpm /10 6 cell
1 10/31/69 4400 100 380 9
II 3/23/70 16,500 100 180 1 3800 100 0 0
23,000 370 2650 0
III 4/3/70 13,500 100 1500 11 2250 100 990 34
11,000 1390 4800 1360
IV 4/23/70 17,000 100 1700 9 2300 100 1800 53
21,000 1600 5000 2000
V 5/1/70 21,000 100 2100 13
29,500 4300
VI 5/7/70 21,190 100 1192 8 1910 100 835 43
18,240 1757 2040 835
Average 8 Average 3224
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FIGURE 6 Uptake of puromycin in 150 min by sensi-
tive and resistant frog cells as a function of the puro-
mycin concentration of the medium . The dotted line
represents equality of the concentration of puromycin
in the medium and intracellularly (including puromycin
derivatives) . The volume of the ICR 2A cells (1.22 X
103 µ3) was calculated from measurements of the diame-
ter of the trypsinized (spherical) cells using the Vickers
image-splitting eyepiece . The volume of the other cells
was derived from the observation that the volume of the
cultured frog cells is a function of their chromosome
number (4) .
An opportunity to investigate in more detail the
correlation of puromycin resistance and uptake was
afforded by the existence of variants of ICR 132
puro 46 and ICR 2A puro 374 whose resistance
was increased by maintenance in puromycin.
Thus, ICR 132 puro 46/20 multiplies in 20 µg/ml,
whereas ICR 132 puro 46 multiplies in 10 µg/ml.
ICR 2A puro 374 grows in 2.5 µg/ml and not in
5 µg/ml, whereas ICR 2A puro 374/10 grows in
10 ug/ml puromycin. Comparison of cell-asso-
ciated radioactivity with that in the medium
(Fig. 6), shows a correlation between resistance
and puromycin exclusion . Furthermore, if the
intracellular radioactivity resulting from 150 min
exposure to 2.5 µg/ml puromycin is plotted
against the maximum concentration (approxi-
mate) in which each strain can multiply (Fig . 7),
the variants with least resistance have the greatest
uptake of drug.
There are a number of considerations which
support the view that puromycin resistance is
determined by the permeability of the cell surface .
It is evident from Fig. 6 that the puromycin
molecule is concentrated in the sensitive cell
lines, probably in the form of puromycin-peptides
or proteins (10). When these puromycin-contain-
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FIGURE 7 Puromycin uptake of six strains of frog cells
as a function of the maximum concentration at which
they multiply. The values for uptake were taken from
Fig. 6.
ing molecules are formed in a cell, they retain the
tritium of the labeled compound ; they are counted
in the uptake experiments as intracellular puro-
mycin. If resistance were the result of interference
with such a coupling reaction inside the cell, the
drug would perhaps not be concentrated ; however,
it is unlikely that the puromycin present in the
cell would be as far below the concentration of
external puromycin as in puro 46 cells (Fig. 6).
The same data indicate that exit of labeled com-
pounds from the cell would have to take place at
a higher rate than entrance of puromycin if re-
sistance were ascribed to the massive formation
of diffusible puromycin derivatives.
DISCUSSION
The two strains of frog cells able to multiply in
puromycin have a number of similarities : the
capacity to retain a level of resistance greater
than the parent line while multiplying in the
absence of the drug; an increase under these condi-
tions of a part of the population less resistant to
puromycin ; the emergence of a population with a
higher degree of resistance after alternate exposure
to medium with and without puromycin . How-
ever, the dissimilarities between the two strains
are more numerous: ICR 2A puro 374 is haploid,
euploid, of a size and chromosome number the
same as that of the parent line ; compared to the
heteroploid variant, it is smaller in size, less re-
sistant, less stable, and was obtained only afterrepeated exposure to increasing concentrations of
puromycin. The ICR 132 variant has four times
the volume and chromosome number of the hap-
loid, twice that of its parent line ; it is aneuploid,
resistant to higher concentrations of puromycin
and more stable. The cells were highly resistant
during, and probably before, a first exposure to
puromycin.
In spite of the differences described above, there
is apparently a common mechanism which enables
the resistant variants of ICR 2A and ICR 132
to multiply in medium containing puromycin .
Resistance is correlated with the degree of uptake
in each case . Such an observation suggests that
the surface membrane of the resistant cell differs
from that of its sensitive progenitor .
The reaction of frog lines of puromycin can be
interpreted as follows : a population never before
exposed to puromycin consists of cells with many
degrees of resistance to the drug in a continuous
distribution. Since resistance to puromycin has
no selective value in normal medium, the average
sensitivity of the population is stable . However, in
puromycin, some cells die, starting with those
at the less resistant end of the distribution . Popu-
lations with a high average resistance will de-
crease slowly ; the range is more likely to include
a few cells resistant enough to form colonies . If
colonies arise at 2 µg/ml puromycin, more will
be found at 1 µg/ml, since there is a continuous
range of resistance (Table I) . It also follows that
the colonies isolated from a cell population will
show a variety of degrees of resistance, as they do .
One has now to consider the question of whether
puromycin resistance arises as a result of gene
mutation or of something quite different . There
are probably a number of sites at which a muta-
tion could decrease the transfer of a molecule :
a change in binding protein, transfer protein or
the shape of a "hole" through which the drug
may pass. It is assumed that one or more of these
entities exist, although little is known about mem-
brane transport in eucaryotic cells for molecules
of this size . Since transport systems show specificity,
one would argue that the majority of mutations
would decrease rather than increase permeability
and so yield resistant cells . However, mutagen
treatment of haploid cells has thus far been inef-
fective in increasing colony incidence . In the
absence of puromycin, resistant cell strains
gradually become less resistant although muta-
tions would tend to decrease permeability.
There are other observations difficult to recon-
cile with a mutation hypothesis . The frequency of
colony formation in various cell lines is different
and independent of ploidy. If a small part only
of the population is unusually resistant, the inter-
mediate stages continue to exist, judging by colony
formation at various drug concentrations and/or
by survival curves . If a change in resistance re-
sulted from one gene mutation, intermediate
stages would be absent at the time the mutation
was finally expressed . If polygenes are invoked
for the spectrum of resistance, it is necessary to
assume either a high mutation rate or a mechanism
for extensive segregation.
Puromycin resistance in frog cells is behaving
as though determined by a large number of units .
Since resistance is the result of a change in the
surface membrane, we should consider the possi-
bility that these units are part of the membrane
and that they are self-determining .
The following model is proposed as a possible
explanation of how the cultured frog cells may
acquire resistance to puromycin. Let us assume
that the degree of uptake is determined by the
percentage of units of an "impermeable" type
which are present in a membrane. The simplest
membrane would consist of two types of units :
I (impermeable) and P (permeable) . As the cells
grow in size, the surface membrane is continually
expanding by the addition of more of these units .
Which one of several types, or perhaps configura-
tions, is incorporated into the membrane may be
dependent on the type, or types, already present at
the point of insertion . The new unit inserted
next to an I unit would be more likely to be an
I unit than a P unit. Therefore, a second assump-
tion for the model is that the units composing a
cell membrane are self-determining and so it is
possible to treat the membrane as a dynamic
population of units . If the self-determining abil-
ity, and thus the adaptive value, of each kind of
unit were equal, the proportion of I and P units
in a membrane would tend to remain the same.
The properties of a cell and its progeny, and
therefore of a cell population, would be stable .
The population would actually be self-determining
at two levels : the unit of membrane structure
(molecular) and the unit of the cell (cellular) .
It follows from this that a shift in the drug re-
sistance of a cell population could occur as a
result of environmental changes affecting the
self-determining potentials of either the mem-
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749brane units or the cellular units, or both. If the
environmental change (addition of puromycin)
acts only at the cellular level, it would be termed
a selective agent . If, however, puromycin acted
in such a way that I membrane units would have
a better chance to determine incoming units
than P units, or even by directly affecting the
structure of a membrane unit, it would act as an
inducer. Although these experiments make it
clear that puromycin acts as a selective agent,
they do not reveal whether or not it also has a
direct effect on membrane structure.
Assuming the model to be applicable, resistant
variants could be selected by exposing a cell
population to cycles of increasing concentrations
of puromycin, interspersed with normal medium
to allow for expansion and diversification of the
cell population. After each cycle, the cell popu-
lation would have a higher proportion of im-
permeable membrane units and thus a greater
probability of containing resistant cells. Such a
cycling procedure yielded the haploid ICR 2A
puro 374 strain. For the heteroploid strain de-
rived without selection by puromycin, it is postu-
lated that the shift in proportion of membrane
units occurred in a small part of the population
by a process of "genetic drift." The absence of
selection against resistant cells in normal medium
combined with the continued random halving of
the membrane units in a cell by division would
make such a result possible. The presence of
more frequent colonies at all the lower concen-
trations of puromycin in this experiment points
to the survival of the intermediate stages in the
process.
Although the self-determining aspect of mem-
brane units has been theoretically analyzed by
Changeux et al. (11) among others, the evidence
for it in membranes is sparse. However, for the
cortex of Paramecium, where patterns can be
microscopically distinguished, Beisson and Sonne-
born (12) have shown that "cortical differenti-
ations are essential for their own reproduction ."
In eucaryotic cells, phenomena such as differ-
entiation, immunity, and transformation share
with drug resistance a number of characteristics
in which self-determined membrane units could
play a role. All exhibit stable phenotypes, cell
surface membrane changes, a requirement for
cell division, a frequency affected by environ-
mental molecules. It should also be noted that
cell surface changes could act like repressors ;
i.e., a decreased permeability to a specific sub-
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strate molecule would result in a deficiency of an
enzyme stabilized by this substrate.
Although present knowledge of membrane
structure may limit the approaches which can
be used to test the model for eucaryotic cells, the
puromycin system in frog cells has a number of
advantages for such an investigation . The amount
of resistance can be assayed, the degree of selec-
tive pressure can be chosen, cell strains which
vary in resistance exist, resistant cell strains with
various chromosome constitutions, including
the haploid, can be compared. Possible correla-
tions with tumorigenicity can be tested by placing
the cells into tadpole tail tips. Finally, the nature
of puromycin resistance can be explored by sub-
stituting the nucleus of a resistant cell for one in
the activated egg using the Briggs and King
technique (13).
The production of stable phenotypes without
changes in the genome is considered to be a
talent of somatic cells . Perhaps one of the mecha-
nisms is based on the existence and properties of
self-determining membrane units .
The isolation and characterization of the puromycin-
resistant variants were performed with the assistance
of A. Klink, S. A. Schatz, and L. E. Sooy. The puro-
mycin uptake experiments were carried out with the
help of R. P. Perry and J. J. Freed. The work from
the beginning benefitted from the advice and ex-
perience of J. J. Freed.
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